Industry: Chemical & Material
Published Date: 2025-02-24
Pages: 142 Pages
Report ld: 4208669
Request Sample
Customized Report
The global market for Beneficial Bacteria was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
North American market for Beneficial Bacteria was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Beneficial Bacteria was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Beneficial Bacteria was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Beneficial Bacteria include Danisco, Kerry, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia, Yakult, Novozymes, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Beneficial Bacteria, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Beneficial Bacteria by region & country, by Type, and by Application.
The Beneficial Bacteria market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beneficial Bacteria.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Beneficial Bacteria manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Beneficial Bacteria in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Beneficial Bacteria in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Beneficial Bacteria Product Introduction
1.2 Global Beneficial Bacteria Market Size Forecast
1.2.1 Global Beneficial Bacteria Sales Value (2020-2031)
1.2.2 Global Beneficial Bacteria Sales Volume (2020-2031)
1.2.3 Global Beneficial Bacteria Sales Price (2020-2031)
1.3 Beneficial Bacteria Market Trends & Drivers
1.3.1 Beneficial Bacteria Industry Trends
1.3.2 Beneficial Bacteria Market Drivers & Opportunity
1.3.3 Beneficial Bacteria Market Challenges
1.3.4 Beneficial Bacteria Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Beneficial Bacteria Players Revenue Ranking (2024)
2.2 Global Beneficial Bacteria Revenue by Company (2020-2025)
2.3 Global Beneficial Bacteria Players Sales Volume Ranking (2024)
2.4 Global Beneficial Bacteria Sales Volume by Company Players (2020-2025)
2.5 Global Beneficial Bacteria Average Price by Company (2020-2025)
2.6 Key Manufacturers Beneficial Bacteria Manufacturing Base and Headquarters
2.7 Key Manufacturers Beneficial Bacteria Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Beneficial Bacteria
2.9 Beneficial Bacteria Market Competitive Analysis
2.9.1 Beneficial Bacteria Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Beneficial Bacteria Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beneficial Bacteria as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Bifidobacterium
3.1.2 Lactobacillus
3.1.3 Others
3.2 Global Beneficial Bacteria Sales Value by Type
3.2.1 Global Beneficial Bacteria Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Beneficial Bacteria Sales Value, by Type (2020-2031)
3.2.3 Global Beneficial Bacteria Sales Value, by Type (%) (2020-2031)
3.3 Global Beneficial Bacteria Sales Volume by Type
3.3.1 Global Beneficial Bacteria Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Beneficial Bacteria Sales Volume, by Type (2020-2031)
3.3.3 Global Beneficial Bacteria Sales Volume, by Type (%) (2020-2031)
3.4 Global Beneficial Bacteria Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food & Beverage
4.1.2 Drugs
4.1.3 Dietary Supplements
4.1.4 Others
4.2 Global Beneficial Bacteria Sales Value by Application
4.2.1 Global Beneficial Bacteria Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Beneficial Bacteria Sales Value, by Application (2020-2031)
4.2.3 Global Beneficial Bacteria Sales Value, by Application (%) (2020-2031)
4.3 Global Beneficial Bacteria Sales Volume by Application
4.3.1 Global Beneficial Bacteria Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Beneficial Bacteria Sales Volume, by Application (2020-2031)
4.3.3 Global Beneficial Bacteria Sales Volume, by Application (%) (2020-2031)
4.4 Global Beneficial Bacteria Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Beneficial Bacteria Sales Value by Region
5.1.1 Global Beneficial Bacteria Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Beneficial Bacteria Sales Value by Region (2020-2025)
5.1.3 Global Beneficial Bacteria Sales Value by Region (2026-2031)
5.1.4 Global Beneficial Bacteria Sales Value by Region (%), (2020-2031)
5.2 Global Beneficial Bacteria Sales Volume by Region
5.2.1 Global Beneficial Bacteria Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Beneficial Bacteria Sales Volume by Region (2020-2025)
5.2.3 Global Beneficial Bacteria Sales Volume by Region (2026-2031)
5.2.4 Global Beneficial Bacteria Sales Volume by Region (%), (2020-2031)
5.3 Global Beneficial Bacteria Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Beneficial Bacteria Sales Value, 2020-2031
5.4.2 North America Beneficial Bacteria Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Beneficial Bacteria Sales Value, 2020-2031
5.5.2 Europe Beneficial Bacteria Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Beneficial Bacteria Sales Value, 2020-2031
5.6.2 Asia Pacific Beneficial Bacteria Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Beneficial Bacteria Sales Value, 2020-2031
5.7.2 South America Beneficial Bacteria Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Beneficial Bacteria Sales Value, 2020-2031
5.8.2 Middle East & Africa Beneficial Bacteria Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Beneficial Bacteria Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Beneficial Bacteria Sales Value
6.2.1 Key Countries/Regions Beneficial Bacteria Sales Value, 2020-2031
6.2.2 Key Countries/Regions Beneficial Bacteria Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Beneficial Bacteria Sales Value, 2020-2031
6.3.2 United States Beneficial Bacteria Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Beneficial Bacteria Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Beneficial Bacteria Sales Value, 2020-2031
6.4.2 Europe Beneficial Bacteria Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Beneficial Bacteria Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Beneficial Bacteria Sales Value, 2020-2031
6.5.2 China Beneficial Bacteria Sales Value by Type (%), 2024 VS 2031
6.5.3 China Beneficial Bacteria Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Beneficial Bacteria Sales Value, 2020-2031
6.6.2 Japan Beneficial Bacteria Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Beneficial Bacteria Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Beneficial Bacteria Sales Value, 2020-2031
6.7.2 South Korea Beneficial Bacteria Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Beneficial Bacteria Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Beneficial Bacteria Sales Value, 2020-2031
6.8.2 Southeast Asia Beneficial Bacteria Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Beneficial Bacteria Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Beneficial Bacteria Sales Value, 2020-2031
6.9.2 India Beneficial Bacteria Sales Value by Type (%), 2024 VS 2031
6.9.3 India Beneficial Bacteria Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Danisco
7.1.1 Danisco Company Information
7.1.2 Danisco Introduction and Business Overview
7.1.3 Danisco Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Danisco Beneficial Bacteria Product Offerings
7.1.5 Danisco Recent Development
7.2 Kerry
7.2.1 Kerry Company Information
7.2.2 Kerry Introduction and Business Overview
7.2.3 Kerry Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Kerry Beneficial Bacteria Product Offerings
7.2.5 Kerry Recent Development
7.3 Lallemand
7.3.1 Lallemand Company Information
7.3.2 Lallemand Introduction and Business Overview
7.3.3 Lallemand Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Lallemand Beneficial Bacteria Product Offerings
7.3.5 Lallemand Recent Development
7.4 China-Biotics
7.4.1 China-Biotics Company Information
7.4.2 China-Biotics Introduction and Business Overview
7.4.3 China-Biotics Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 China-Biotics Beneficial Bacteria Product Offerings
7.4.5 China-Biotics Recent Development
7.5 Nestle
7.5.1 Nestle Company Information
7.5.2 Nestle Introduction and Business Overview
7.5.3 Nestle Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Nestle Beneficial Bacteria Product Offerings
7.5.5 Nestle Recent Development
7.6 Danone
7.6.1 Danone Company Information
7.6.2 Danone Introduction and Business Overview
7.6.3 Danone Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Danone Beneficial Bacteria Product Offerings
7.6.5 Danone Recent Development
7.7 Probi
7.7.1 Probi Company Information
7.7.2 Probi Introduction and Business Overview
7.7.3 Probi Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Probi Beneficial Bacteria Product Offerings
7.7.5 Probi Recent Development
7.8 BioGaia
7.8.1 BioGaia Company Information
7.8.2 BioGaia Introduction and Business Overview
7.8.3 BioGaia Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 BioGaia Beneficial Bacteria Product Offerings
7.8.5 BioGaia Recent Development
7.9 Yakult
7.9.1 Yakult Company Information
7.9.2 Yakult Introduction and Business Overview
7.9.3 Yakult Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Yakult Beneficial Bacteria Product Offerings
7.9.5 Yakult Recent Development
7.10 Novozymes
7.10.1 Novozymes Company Information
7.10.2 Novozymes Introduction and Business Overview
7.10.3 Novozymes Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Novozymes Beneficial Bacteria Product Offerings
7.10.5 Novozymes Recent Development
7.11 Valio
7.11.1 Valio Company Information
7.11.2 Valio Introduction and Business Overview
7.11.3 Valio Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Valio Beneficial Bacteria Product Offerings
7.11.5 Valio Recent Development
7.12 Glory Biotech
7.12.1 Glory Biotech Company Information
7.12.2 Glory Biotech Introduction and Business Overview
7.12.3 Glory Biotech Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Glory Biotech Beneficial Bacteria Product Offerings
7.12.5 Glory Biotech Recent Development
7.13 Ganeden
7.13.1 Ganeden Company Information
7.13.2 Ganeden Introduction and Business Overview
7.13.3 Ganeden Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Ganeden Beneficial Bacteria Product Offerings
7.13.5 Ganeden Recent Development
7.14 Morinaga Milk Industry
7.14.1 Morinaga Milk Industry Company Information
7.14.2 Morinaga Milk Industry Introduction and Business Overview
7.14.3 Morinaga Milk Industry Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Morinaga Milk Industry Beneficial Bacteria Product Offerings
7.14.5 Morinaga Milk Industry Recent Development
7.15 Sabinsa
7.15.1 Sabinsa Company Information
7.15.2 Sabinsa Introduction and Business Overview
7.15.3 Sabinsa Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Sabinsa Beneficial Bacteria Product Offerings
7.15.5 Sabinsa Recent Development
7.16 Greentech
7.16.1 Greentech Company Information
7.16.2 Greentech Introduction and Business Overview
7.16.3 Greentech Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Greentech Beneficial Bacteria Product Offerings
7.16.5 Greentech Recent Development
7.17 Bioriginal
7.17.1 Bioriginal Company Information
7.17.2 Bioriginal Introduction and Business Overview
7.17.3 Bioriginal Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Bioriginal Beneficial Bacteria Product Offerings
7.17.5 Bioriginal Recent Development
7.18 Biosearch Life
7.18.1 Biosearch Life Company Information
7.18.2 Biosearch Life Introduction and Business Overview
7.18.3 Biosearch Life Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Biosearch Life Beneficial Bacteria Product Offerings
7.18.5 Biosearch Life Recent Development
7.19 UAS Laboratories
7.19.1 UAS Laboratories Company Information
7.19.2 UAS Laboratories Introduction and Business Overview
7.19.3 UAS Laboratories Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 UAS Laboratories Beneficial Bacteria Product Offerings
7.19.5 UAS Laboratories Recent Development
7.20 Synbiotech
7.20.1 Synbiotech Company Information
7.20.2 Synbiotech Introduction and Business Overview
7.20.3 Synbiotech Beneficial Bacteria Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Synbiotech Beneficial Bacteria Product Offerings
7.20.5 Synbiotech Recent Development
8 Industry Chain Analysis
8.1 Beneficial Bacteria Industrial Chain
8.2 Beneficial Bacteria Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Beneficial Bacteria Sales Model
8.5.2 Sales Channel
8.5.3 Beneficial Bacteria Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Beneficial Bacteria was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 150
USD 3950.00
(Single User License)
The global Beneficial Bacteria market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 150
USD 2900.00
(Single User License)
The global Beneficial Bacteria market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 175
USD 4900.00
(Single User License)
The global Beneficial Bacteria market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 110
USD 4250.00
(Single User License)
The global market for Beneficial Bacteria was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 107
USD 2900.00
(Single User License)
The global Beneficial Bacteria market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-26
Pages: 129
USD 4900.00
(Single User License)
The global market for Beneficial Bacteria was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 150
The global Beneficial Bacteria market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 150
The global Beneficial Bacteria market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 175
The global Beneficial Bacteria market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 110
The global market for Beneficial Bacteria was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 107
The global Beneficial Bacteria market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-26
Pages: 129
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now